Double your impact this holiday season
Survival statistics for kidney cancer
Survival statistics for kidney cancer are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular person’s chances of survival.
There are many different ways to measure and report cancer survival statistics. Your doctor can explain the statistics for kidney cancer and what they mean to you.
Net survival represents the probability of surviving cancer in the absence of other causes of death. It is used to give an estimate of the percentage of people who will survive their cancer.
In Canada, the 5-year net survival for kidney cancer is 67%. This means that, on average, about 67% of people diagnosed with kidney cancer will survive for at least 5 years.
Relative survival looks at how likely people with cancer are to survive after their diagnosis compared to people in the general population who do not have cancer, but who share similar characteristics (such as age and sex).
Survival by stage
Survival varies with each stage of kidney cancer. The following factors can also affect survival for kidney cancer.
- Generally, the earlier kidney cancer is diagnosed and treated, the better the outcome.
- Different types of kidney cancer may respond differently to treatment.
There are no specific Canadian statistics available for the different stages of kidney cancer. The following information comes from a variety of sources and may include statistics from other countries.
|Stage||5-year relative survival|
Questions about survival
Talk to your doctor about your prognosis. A prognosis depends on many factors, including:
- your health history
- the type of cancer
- the stage
- certain characteristics of the cancer
- the treatments chosen
- how the cancer responds to treatment
Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.
Together we can reduce the burden of cancer
Last year, we only had the resources available to fund 40% of high-priority research projects. Imagine the impact we could have if we were able to fund 100%.